Hypoparathyroidism that does not respond adequately to calcium and vitamin D supplementation may require treatment with recombinant parathyroid hormone (rhPTH 1 - 84), which also may decrease the risk of long-term hypoparathyroidism complications (eg, hypercalciuria, decreased bone strength), and lower the doses of calcium and vitamin D needed.